Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

被引：0
|
作者：
Hwang, W. Y. [1 ]
Kim, S. I. [2 ]
Lee, M. [2 ]
Kim, K. [1 ]
No, J. H. [1 ]
Kim, J. W. [2 ]
Kim, Y. B. [1 ]
Suh, D. H. [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页码：346 / 347
页数：2
相关论文
共 50 条
  • [41] IMPACT OF SECONDARY CYTOREDUCTIVE SURGERY FOR RECURRENT EPITHELIAL OVARIAN CANCER
    Chiva de Agustin, L.
    Garcia Lavandeira, S.
    Alonso Salvador, S.
    Castellanos Alarcon, T.
    Lapuente Sastre, F.
    Gonzalez Martin, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [42] An estimation of total number of cycles of chemotherapy in patients with epithelial ovarian cancer worldwide
    Nagao, S.
    Ohishi, R.
    Iwasa, N.
    Shimizu, M.
    Goto, T.
    Fujiwara, K.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S56 - S57
  • [43] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Is the number of preoperative cycles important?
    Cantu de Leon, D.
    Gallardo-Alvarado, L. N.
    Salcedo-Hernandez, R. A.
    Perez-Montiel, D.
    Ramirez, R.
    Barquet-Munoz, S. A.
    Perez Quintanilla, M.
    Rivera-Buendia, F.
    Del Real, S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 122 - 123
  • [44] Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer
    Woelber, L.
    Jung, S.
    Eulenburg, C.
    Mueller, V.
    Schwarz, J.
    Jaenicke, F.
    Mahner, S.
    EJSO, 2010, 36 (06): : 583 - 588
  • [45] OVERALL SURVIVAL PROGNOSTIC FACTORS IN RECURRENT EPITHELIAL OVARIAN CANCER IN TUNISIA
    Berrazaga, Y.
    Mejri, N.
    Rachdi, H.
    Ferjaoui, M.
    Daoud, N.
    Boussen, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A114 - A114
  • [46] Chemotherapy for recurrent ovarian cancer
    Kaye, SB
    LANCET, 2003, 361 (9375): : 2094 - 2095
  • [47] The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer
    Bakir, Mehmet Sait
    Birge, Ozer
    Karadag, Ceyda
    Dogan, Selen
    Tuncer, Hasan Aykut
    Simsek, Tayup
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1198 - 1204
  • [48] Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer
    Zang, RY
    Zhang, ZY
    Li, ZT
    Chen, J
    Tang, MQ
    Liu, Q
    Cai, SM
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (01) : 24 - 30
  • [49] Obesity correlates with overall survival in women with recurrent epithelial ovarian cancer
    Tran, Arthur
    Rimel, B. J.
    Walsh, Christine
    Cass, Ilana
    Karlan, Beth Y.
    Li, Andrew J.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 261 - 262
  • [50] Secondary cytoreductive surgery for localized recurrent epithelial ovarian cancer: Analysis of prognostic factors and survival outcome.
    Salani, R.
    Santillan, A.
    Zahurak, M.
    Giuntoli, R.
    Gardner, G. J.
    Armstrong, D. K.
    Bristow, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 262S - 262S
12345